國家衛生研究院 NHRI:
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 852310      Online Users : 1522
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version

    Collection

    Periodical Articles [32/32]
    Conference Papers/Meeting Abstract [8/8]

    Community Statistics


    Item counts issued in 3 years:32(80.00%)
    Items With Fulltext:40(100.00%)

    Download counts of the item
    Download times greater than 0:40(100.00%)
    Download times greater than 100:31(77.50%)
    Total Bitstream Download Counts:6455(0.12%)

    Last Update: 2024-11-28 14:39

    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 1-10 of 40. (4 Page(s) Totally)
    1 2 3 4 > >>
    View [10|25|50] records per page

    DateTitleRelation
    2024-11 Cytoplasmic lipid droplets predict worse prognosis in diffuse large B-cell lymphoma: Next-generation sequencing deciphering lipogenic genes American Journal of Surgical Pathology. 2024 Nov 1;48(11):1425-1438.
    2024-11 Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: A cross-trial, patient-level analysis Lancet. Oncology. 2024 Nov;25(11):1465-1475.
    2024-10 A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study Oncologist. 2024 Oct 3;29(10):e1396-e1405.
    2024-08-28 Clinical outcomes and histologic findings of patients with hepatocellular carcinoma with durable partial response or durable stable disease after receiving atezolizumab plus bevacizumab Journal of Clinical Oncology. 2024 Aug 28;Article in Press.
    2024-06 Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation Biomedical Journal. 2024 Jun;47(3):Article number 100696.
    2024-05 Impact of previous S-1 treatment on efficacy of liposomal irinotecan plus 5-fluorouracil and leucovorin in patients with metastatic pancreatic cancer Pancreatology. 2024 May;24(3):600-607.
    2024-02-15 Neuron-derived neurotensin promotes pancreatic cancer invasiveness and gemcitabine resistance via the NTSR1/Akt pathway American Journal of Cancer Research. 2024 Feb 15;14(2):448-466.
    2024-02-13 Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: A multicenter study in Taiwan Journal of Biomedical Science. 2024 Feb 13;31:Article number 21.
    2024-02-01 Outcomes of post-immunotherapy durable responders of advanced hepatocellular carcinoma- with emphasis on locoregional therapy for oligoprogression Liver Cancer. 2024 Feb 01;Article in Press.
    2023-11 Nivolumab plus ipilimumab (N plus I) for potentially resectable hepatocellular carcinoma (HCC): Efficacy and surgical outcome Annals of Oncology. 2023 Nov;34(Suppl. 3):S1390.

    Showing items 1-10 of 40. (4 Page(s) Totally)
    1 2 3 4 > >>
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback